Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
NCT07550465 QLS1410 Hyperaldosteronism Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07550465 clinical trial report covering QLS1410, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07550517 Lutetium (177 Lu) Vipivotide Tetraxetan Localized Prostate Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07550517 clinical trial report covering Lutetium (177 Lu) Vipivotide Tetraxetan, Phase 2, endpoints, sponsor, geography, readout timing and development
Latest Hotspot
8 min read
NCT07551427 Rovadicitinib Post-essential thrombocythemia myelofibrosis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07551427 clinical trial report covering Rovadicitinib, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07550855 Rituximab Follicular Lymphoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07550855 clinical trial report covering Rituximab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07550595 Oritavancin Diphosphate Gram-Positive Bacterial Infections Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07550595 clinical trial report covering Oritavancin Diphosphate, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
![NCT07549841 [68Ga]FAPI-46 Transthyretin Amyloid Cardiomyopathy Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook](https://synapse-static.patsnap.com/strapi-static/Blog_cover_04_d2b0c3c766.jpg)
Latest Hotspot
8 min read
NCT07549841 [68Ga]FAPI-46 Transthyretin Amyloid Cardiomyopathy Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07549841 clinical trial report covering [68Ga]FAPI-46, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
ChiCTR2600123414 Fluzoparib Ovarian Cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
ChiCTR2600123414 clinical trial report covering Fluzoparib, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07551882 Oxytocin Borderline Personality Disorder Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07551882 clinical trial report covering Oxytocin, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07549451 Imetelstat Myelodysplastic-Myeloproliferative Diseases Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07549451 clinical trial report covering Imetelstat, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
ChiCTR2600123531 Thalidomide Histiocytosis, Langerhans-Cell Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
ChiCTR2600123531 clinical trial report covering Thalidomide, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
ChiCTR2600123501 Albumin-Bound Paclitaxel Urothelial Carcinoma of the Urinary Bladder Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
ChiCTR2600123501 clinical trial report covering Albumin-Bound Paclitaxel, Phase 2, endpoints, sponsor, geography, readout timing and development white spac
Latest Hotspot
8 min read
NCT07551739 HSK55718 Pain, Postoperative Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07551739 clinical trial report covering HSK55718, Phase 2, endpoints, sponsor, geography, readout timing and development white space.